Granulocyte transfusions: a review

[1]Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993;81:1675–8.10.1182/blood.V81.7.1675.1675Search in Google Scholar

[2]Strauss RG. Clinical perspectives of granulocyte transfusions: efficacy to date. J Clin Apher 1995;10: 114–8.10.1002/jca.2920100303Search in Google Scholar

[3]Vamvakas EC, Pineda AA.Determinants of the efficacy of prophylactic granulocyte transfusions: a metaanalysis. J Clin Apher 1997;12:74–81.10.1002/(SICI)1098-1101(1997)12:2<74::AID-JCA4>3.0.CO;2-6Search in Google Scholar

[4]Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man.J Clin Inves 1975;56:808–13.10.1172/JCI108159Search in Google Scholar

[5]Liles WC, Huang JE, Llewellyn C, Sengupta D, Price TH, Dale DC.A comparative trial of granulocytecolony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal vol- unteers.Transfusion 1997;37:182–7.10.1046/j.1537-2995.1997.37297203521.xSearch in Google Scholar

[6]Leitman SF, Oblitas JM. Optimization of granulocyta- pheresis mobilization regimens using granulocyte stimulating factor (G-CSF) and dexamethasone. Transfusion 1997;37(Suppl):67S.Search in Google Scholar

[7]de Haas M, Kleijer M,van Zweiten R, Roos D,von dem Borne AEGKr. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403–13.10.1182/blood.V86.6.2403.bloodjournal8662403Search in Google Scholar

[8]Lord LI, Bronchud MH, Owens S,et al.The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 1989;86:9499–503.10.1073/pnas.86.23.9499Search in Google Scholar

[9]Bensinger WI, Price TH, Dale DC,et al.The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81: 1883–8.10.1182/blood.V81.7.1883.1883Search in Google Scholar

[10]Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866–71.10.1182/blood.V81.11.2866.2866Search in Google Scholar

[11]Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O’Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrate from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apher 1995;10:188–93.10.1002/jca.2920100406Search in Google Scholar

[12]Lane TA, Law P, Maruyama M,et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995;85:275–82.10.1182/blood.V85.1.275.bloodjournal851275Search in Google Scholar

[13]Anderlini P, Przepiorka D, Seong D,et al. Clinical toxicity and laboratory effects of granulocyte-colonystimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors,and analysis of charges for the procedures. Transfusion 1996; 36:590–5.10.1046/j.1537-2995.1996.36796323057.x8701453Search in Google Scholar

[14]Anderlini P, Przepiorka D, Seong D, Champlin R, Korbling M.Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol 1996;94:155–8.10.1046/j.1365-2141.1996.d01-1778.x8757527Search in Google Scholar

[15]Stroncek DF, Clay ME, Petzoldt ML,et al.Treatment of normal individuals with G-CSF: donor experiences and the effects on peripheral blood CD34+ cell counts and the collection of peripheral blood stem cells.Transfusion 1996;36:601–10.10.1046/j.1537-2995.1996.36796323059.x8701455Search in Google Scholar

[16]Stroncek DF, Clay ME, Smith J, Ilstrup S, Oldham F, McCullough J. Changes in blood counts following the administration of G-CSF and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996;36:596–600.10.1046/j.1537-2995.1996.36796323058.x8701454Search in Google Scholar

[17]Lee J-H, Leitman SF, Klein HG.A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis. Blood 1995;86:4662–6.10.1182/blood.V86.12.4662.bloodjournal86124662Search in Google Scholar

[18]Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1997.Search in Google Scholar

[19]Lane TA,Windle B. Granulocyte concentrate function during preservation: effect of temperature. Blood 1979;54:216–25.10.1182/blood.V54.1.216.216Search in Google Scholar

[20]McCullough J,Weiblen BJ, Fine D.Effects of storage of granulocytes on their fate in vivo. Transfusion 1983;23:20–4.10.1046/j.1537-2995.1983.23183147298.x6338628Search in Google Scholar

[21]Coates TD, Wolach B, Tzeng DY, Higgins C, Baehner RL, Boxer LA.The mechanisms of action of the antiinflammatory agents dexamethasone and auranofin in human polymorphonuclear leukocytes. Blood 1983;62:1070–7.10.1182/blood.V62.5.1070.1070Search in Google Scholar

[22]Clark RAF, Gallin JI, Fauci AS. Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. Blood 1979;53:633–41.10.1182/blood.V53.4.633.633Search in Google Scholar

[23]Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy:mechanisms of action and clinical consider- ations.Ann Int Med 1976;84:304–15.10.7326/0003-4819-84-3-304769625Search in Google Scholar

[24]Ward PA. The chemosuppression of chemotaxis. J Exp Med 1966;24:209–25.10.1084/jem.124.2.20921804725950689Search in Google Scholar

[25]Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977;297:1033–6.10.1056/NEJM197711102971904909548Search in Google Scholar

[26]Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effects of collection method, donor corticoid treatment and short-term storage. Blood 1979;54:977–86.10.1182/blood.V54.5.977.977Search in Google Scholar

[27]Kerst JM, de Haas M, van der Schoot CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265–72.10.1182/blood.V82.11.3265.3265Search in Google Scholar

[28]Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplantation 1997;19:809–12.10.1038/sj.bmt.17007499134173Search in Google Scholar

[29]Leitman SF, Oblitas JM, Emmons R, Dunn DE,Young NS. Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections. Blood 1996;88:331a.Search in Google Scholar

[30]McCullough J, Clay ME, Hurd D, Richards K, Ludvigsen C, Forstrom L. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium labeled granulocytes. Blood 1986;67:522–8.10.1182/blood.V67.2.522.522Search in Google Scholar

[31]Weiblen BJ,Forstrom L, McCullough J. Studies of the kinetics of indium-111-labeled granulocytes. J Lab Clin Med 1979;94:246–55.Search in Google Scholar

[32]Liles WC, Kiener PA, Ledbetter JA,Aruffo A,Klebanoff SJ. Differential expression of Fas (DC95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.J Exp Med 1996;184:429–40.10.1084/jem.184.2.42921927128760796Search in Google Scholar

[33]Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181–8.10.1182/blood.V86.8.3181.3181Search in Google Scholar

[34]Schiffer CA,Aisner J, Daly PA,et al.Alloimmunization following prophylactic granulocyte transfusions. Blood 1979;54:766–74.10.1182/blood.V54.4.766.766Search in Google Scholar

[35]Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF.Alloimmunization after granulocyte trans- fusions.Transfusion 1996;36:1009–15.10.1046/j.1537-2995.1996.36111297091747.x8937413Search in Google Scholar

[36]Goldstein IM, Eyre JH, Terasaki PI, Henderson ES, Graw RG Jr. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion 1971;11:19–24.10.1111/j.1537-2995.1971.tb04369.x5544557Search in Google Scholar

[37]Popovsky MA, Abel MD, Moore SB.Transfusion-relat- ed acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185–9.10.1164/arrd.1983.128.1.1856603182Search in Google Scholar

[38]Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983;62:354–60.10.1182/blood.V62.2.354.354Search in Google Scholar

[39]DePalma L, Leitman SF, Carter CS, Gallin JI. Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell antibodies.Transfusion 1989;29:421–3.10.1046/j.1537-2995.1989.29589284143.x2734822Search in Google Scholar

[40]Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981;304:1185–9.10.1056/NEJM1981051430420017219459Search in Google Scholar

[41]Eastlund DT, Charbonneau TT. Superoxide generation and cytotactic response of irradiated neu- trophils.Transfusion 1988;26:368–70.Search in Google Scholar